Ekkehard Schütz
2023
In 2023, Ekkehard Schütz earned a total compensation of $575.2K as Chief Science Officer at Oncocyte Corp.
Compensation breakdown
| Bonus | $132,700 |
|---|---|
| Option Awards | $165,892 |
| Salary | $242,028 |
| Other | $34,547 |
| Total | $575,167 |
Schütz received $242K in salary, accounting for 42% of the total pay in 2023.
Schütz also received $132.7K in bonus, $165.9K in option awards and $34.5K in other compensation.
Rankings
In 2023, Ekkehard Schütz's compensation ranked 1,860th out of 2,983 executives tracked by ExecPay. In other words, Schütz earned more than 37.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,860 out of 2,983 | 38th |
Division Manufacturing | 1,069 out of 1,637 | 35th |
Major group Chemicals And Allied Products | 665 out of 906 | 27th |
Industry group Drugs | 648 out of 869 | 25th |
Industry In Vitro and In Vivo Diagnostic Substances | 6 out of 14 | 57th |
Source: SEC filing on April 29, 2024.
Schütz's colleagues
We found three more compensation records of executives who worked with Ekkehard Schütz at Oncocyte Corp in 2023.